Cargando…

Invasive Multidrug-Resistant emm93.0 Streptococcus pyogenes Strain Harboring a Novel Genomic Island, Israel, 2017–2019

Invasive group A Streptococcus (iGAS) infections have increased in Israel since 2016 as successful lineages have emerged. We report the emergence and outbreak of a multidrug-resistant S. pyogenes emm93.0, sequence type 10, among iGAS infections in Israel since 2017. This type has been observed very...

Descripción completa

Detalles Bibliográficos
Autores principales: Ron, Merav, Brosh-Nissimov, Tal, Korenman, Zinaida, Treygerman, Orit, Sagi, Orli, Valinsky, Lea, Rokney, Assaf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714194/
https://www.ncbi.nlm.nih.gov/pubmed/34932442
http://dx.doi.org/10.3201/eid2801.210733
_version_ 1784623868083699712
author Ron, Merav
Brosh-Nissimov, Tal
Korenman, Zinaida
Treygerman, Orit
Sagi, Orli
Valinsky, Lea
Rokney, Assaf
author_facet Ron, Merav
Brosh-Nissimov, Tal
Korenman, Zinaida
Treygerman, Orit
Sagi, Orli
Valinsky, Lea
Rokney, Assaf
author_sort Ron, Merav
collection PubMed
description Invasive group A Streptococcus (iGAS) infections have increased in Israel since 2016 as successful lineages have emerged. We report the emergence and outbreak of a multidrug-resistant S. pyogenes emm93.0, sequence type 10, among iGAS infections in Israel since 2017. This type has been observed very rarely in other countries. During this period, emm93.0 was the cause of 116 infections in Israel and became the leading type during 2018. Most of the infections were from bacteremia (75%), and most patients were male (76%). We observed infections across Israel, mainly in adults. Of note, we observed multidrug resistance for clindamycin, tetracycline, and trimethoprim/sulfamethoxazole. Whole-genome sequencing confirmed clonality among geographically disseminated isolates. The local emm93.0 sequence type 10 clone contained a novel genomic island harboring the resistance genes lsa(E), lnu(B), and ant (6)-Ia aph(3′)-III. Further phenotypic and genomic studies are required to determine the prevalence of this resistance element in other iGAS types.
format Online
Article
Text
id pubmed-8714194
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-87141942022-01-04 Invasive Multidrug-Resistant emm93.0 Streptococcus pyogenes Strain Harboring a Novel Genomic Island, Israel, 2017–2019 Ron, Merav Brosh-Nissimov, Tal Korenman, Zinaida Treygerman, Orit Sagi, Orli Valinsky, Lea Rokney, Assaf Emerg Infect Dis Research Invasive group A Streptococcus (iGAS) infections have increased in Israel since 2016 as successful lineages have emerged. We report the emergence and outbreak of a multidrug-resistant S. pyogenes emm93.0, sequence type 10, among iGAS infections in Israel since 2017. This type has been observed very rarely in other countries. During this period, emm93.0 was the cause of 116 infections in Israel and became the leading type during 2018. Most of the infections were from bacteremia (75%), and most patients were male (76%). We observed infections across Israel, mainly in adults. Of note, we observed multidrug resistance for clindamycin, tetracycline, and trimethoprim/sulfamethoxazole. Whole-genome sequencing confirmed clonality among geographically disseminated isolates. The local emm93.0 sequence type 10 clone contained a novel genomic island harboring the resistance genes lsa(E), lnu(B), and ant (6)-Ia aph(3′)-III. Further phenotypic and genomic studies are required to determine the prevalence of this resistance element in other iGAS types. Centers for Disease Control and Prevention 2022-01 /pmc/articles/PMC8714194/ /pubmed/34932442 http://dx.doi.org/10.3201/eid2801.210733 Text en https://creativecommons.org/licenses/by/4.0/Emerging Infectious Diseases is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Research
Ron, Merav
Brosh-Nissimov, Tal
Korenman, Zinaida
Treygerman, Orit
Sagi, Orli
Valinsky, Lea
Rokney, Assaf
Invasive Multidrug-Resistant emm93.0 Streptococcus pyogenes Strain Harboring a Novel Genomic Island, Israel, 2017–2019
title Invasive Multidrug-Resistant emm93.0 Streptococcus pyogenes Strain Harboring a Novel Genomic Island, Israel, 2017–2019
title_full Invasive Multidrug-Resistant emm93.0 Streptococcus pyogenes Strain Harboring a Novel Genomic Island, Israel, 2017–2019
title_fullStr Invasive Multidrug-Resistant emm93.0 Streptococcus pyogenes Strain Harboring a Novel Genomic Island, Israel, 2017–2019
title_full_unstemmed Invasive Multidrug-Resistant emm93.0 Streptococcus pyogenes Strain Harboring a Novel Genomic Island, Israel, 2017–2019
title_short Invasive Multidrug-Resistant emm93.0 Streptococcus pyogenes Strain Harboring a Novel Genomic Island, Israel, 2017–2019
title_sort invasive multidrug-resistant emm93.0 streptococcus pyogenes strain harboring a novel genomic island, israel, 2017–2019
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714194/
https://www.ncbi.nlm.nih.gov/pubmed/34932442
http://dx.doi.org/10.3201/eid2801.210733
work_keys_str_mv AT ronmerav invasivemultidrugresistantemm930streptococcuspyogenesstrainharboringanovelgenomicislandisrael20172019
AT broshnissimovtal invasivemultidrugresistantemm930streptococcuspyogenesstrainharboringanovelgenomicislandisrael20172019
AT korenmanzinaida invasivemultidrugresistantemm930streptococcuspyogenesstrainharboringanovelgenomicislandisrael20172019
AT treygermanorit invasivemultidrugresistantemm930streptococcuspyogenesstrainharboringanovelgenomicislandisrael20172019
AT sagiorli invasivemultidrugresistantemm930streptococcuspyogenesstrainharboringanovelgenomicislandisrael20172019
AT valinskylea invasivemultidrugresistantemm930streptococcuspyogenesstrainharboringanovelgenomicislandisrael20172019
AT rokneyassaf invasivemultidrugresistantemm930streptococcuspyogenesstrainharboringanovelgenomicislandisrael20172019